SCHEMBL23558388

SCHEMBL23558388

O=C1CCc2cc(-c3nc(-c4ccccc4O)no3)ccc2N1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 4/20 0.49
▸ CYP11B2 P19099 4/20 0.49
▸ CYP2C9 P11712 2/20 0.49
▸ CYP2D6 P10635 1/20 0.49
▸ CYP2B6 P20813 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ CASP3 P42574 2/20 0.49
▸ SENP8 Q96LD8 2/20 0.49
▸ SENP7 Q9BQF6 2/20 0.49
▸ SENP6 Q9GZR1 2/20 0.49
▸ CYP1A2 P05177 2/20 0.46
▸ PDE3B Q13370 2/20 0.46
▸ PDE3A Q14432 2/20 0.46
▸ TBXAS1 P24557 1/20 0.46
▸ MAPT P10636 4/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ POLB P06746 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ CYP19A1 P11511 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23524119 0.87 GRIA1 (0.53) CYP11B1CYP11B2CYP2C9CYP2D6CYP2B6
SCHEMBL30355544 0.87 GRIA1 (0.53) CYP11B1CYP11B2CYP2C9CYP2D6CYP2B6
SCHEMBL30355642 0.78 CYP11B1 (0.70) CYP11B1CYP11B2CYP2C9CYP2D6CYP2B6
SCHEMBL23524034 0.78 CYP11B1 (0.70) CYP11B1CYP11B2CYP2C9CYP2D6CYP2B6
SCHEMBL23524427 0.72 MAPT (0.46) CYP11B1CYP11B2CYP2C9CYP2D6CYP2B6
SCHEMBL23558362 0.70 MAPT (0.51) CYP11B1CYP11B2CYP2C9CYP2D6CYP2B6
SCHEMBL13606307 0.70 CASP3 (0.77) CYP2C9CYP2C19CASP3SENP8SENP7
SCHEMBL30355778 0.70 S1PR1 (0.43) CYP11B1CYP11B2CYP2C9CYP2D6CYP2B6
SCHEMBL23524097 0.70 S1PR1 (0.43) CYP11B1CYP11B2CYP2C9CYP2D6CYP2B6
SCHEMBL3306566 0.69 KIF11 (0.69) CYP11B1CYP11B2CYP2C9CYP2D6CYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210188826-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME TREVENA, INC. 2021-06-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210188826-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME S1PR1, S1PR2, S1PR3 CYP11B1 1869/4885CYP11B2 2298/4885CYP2C9 4770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback